Intravenous Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global Intravenous Solutions Market, valued at approximately US$ 14 billion in 2024, is anticipated to witness significant growth, reaching a projected valuation of nearly US$ 32 billion by the end of 2031. The demand for intravenous solutions is expected to surge due to the sedentary lifestyle affecting around 39% of the world's population, particularly among the aging demographic facing chronic conditions like cancer, heart disease, stroke, diabetes, and arthritis.

Intravenous solutions play a crucial role in providing necessary nutrients to patients in Intensive Care Units (ICUs), with higher efficacy linked to quicker response times. The market's expansion is significantly contributed to by therapy with intravenous solutions.

Key Drivers for the Intravenous Solutions Market:

Severe Dehydration Treatment: Intravenous (IV) fluids play a pivotal role in treating severe dehydration, particularly resulting from diseases like diarrhea, which deplete the body's fluid reserves. According to the World Health Organization (WHO), in 2017, diarrhea accounted for approximately 525 thousand annual deaths among children under five years old, making it the second leading cause of mortality in this age group. IV fluids prove extremely helpful in averting fatalities induced by disease-related dehydration and fluid loss.

Premature Births: The incidence of premature births has been steadily increasing, with one in ten babies born in the nation in 2019 experiencing premature birth. IV solutions, rich in proteins, calories, and electrolytes, are anticipated to witness a surge in demand alongside the rising occurrence of preterm births.

Cost Savings: Standard intravenous solutions offer cost savings attributed to a reduction in administering supplies and nursing time. While normal (0.9%) saline is generally less expensive than other fluid preparations, the cost of intravenous fluid varies significantly between fluid types and nations. Notably, the use of a common intravenous solution administering process, compared to a 2-in-1 plus a separate IVFE injection, reduces nursing time by half (2.2 vs. 4.3 hours).

Market Outlook for 2024 to 2031:

The Intravenous Solutions Market is poised for robust growth in the coming decade, driven by the aforementioned key drivers. The demand for IV therapy is expected to remain strong, with the United States leading the market as the largest consumer, presenting a substantial absolute dollar opportunity.

In conclusion, the sales analysis underscores the critical role of Intravenous Solutions in healthcare, addressing conditions such as severe dehydration and premature births. As the market continues to expand, the emphasis on cost savings and the growing need for IV therapy indicate a positive outlook for the Intravenous Solutions Market in the years ahead.

Key Impact Points:

Increased Demand during the Pandemic: The imperative need for intravenous solutions became more pronounced as COVID-19 patients flooded ICUs globally. The ability of intravenous fluids to provide crucial nutrients to patients on ventilators contributed to their heightened demand.

WHO Recommendations: The World Health Organization underscored the significance of intravenous fluids, particularly for patients experiencing respiratory failure. The recommendation added further impetus to the utilization of intravenous solutions in the management of COVID-19 cases.

Strain on Critical Care Facilities: Critical care wards operating at full capacity in England in January 2021 highlighted the strain on healthcare facilities during the peak of the pandemic. The demand for intravenous fluids was a crucial component in managing patients, especially the older demographic, who faced challenges in oral food intake due to ventilation.

Anticipated Future Trends:

The surge in demand for intravenous solutions during the COVID-19 pandemic is expected to have a lasting impact, with an anticipation of continued growth in the coming years. As the healthcare sector adapts to evolving challenges, the importance of intravenous fluids in critical care scenarios is likely to remain high.

In conclusion, the COVID-19 pandemic has underscored the indispensable role of intravenous solutions in the treatment and care of critically ill patients. The increased demand witnessed during the pandemic is expected to shape future trends, emphasizing the ongoing importance of intravenous solutions in global healthcare.

Region-wise Insights:

The Asia Pacific Intravenous Solutions Market is expected to witness substantial growth, driven by a projected high CAGR. China and India contribute significantly to preterm births globally, with premature infants facing greater risks of growth issues and illnesses. As a result, early parenteral nutrition with adequate energy and amino acids is expected to be a key factor driving the market in the Asia Pacific region.

Country-wise Insights:

U.S. Intravenous Solutions Market Analysis: The United States is poised to offer significant growth opportunities in the Intravenous Solutions Market. The market is projected to experience robust growth from 2024 to 2031, driven by an increased demand for IV medications due to the prevalence of influenza cases.

U.K. Intravenous Solutions Market Analysis: The Intravenous Solutions Market in the United Kingdom is expected to grow steadily during the forecast period, with a substantial absolute dollar opportunity. By 2031, the market is anticipated to reach a noteworthy valuation, driven by consistent growth between 2024 and 2031.

Japan Intravenous Solutions Market Analysis: In Japan, the Intravenous Solutions Market is set to expand and reach a considerable size by 2031, with an absolute dollar opportunity during the forecast period. The market is expected to achieve steady growth in this timeframe.

South Korea Intravenous Solutions Market Analysis: The Intravenous Solutions Market in South Korea is expected to present notable opportunities, with a growth trajectory between 2024 and 2031. The market is projected to achieve a significant size during this period.

Competitive Analysis:

Key players in the Intravenous Solutions Market, including-

Key Companies Profiled

Fresenius Kabi
Sino-Swed Pharmaceutical Corp., Ltd
Hospira
Amanta Healthcare
Otsuka Pharmaceutical Co., Ltd
Sichuan Kelun Pharmaceutical Co., Ltd
Terumo Corporation
Baxter
B. Braun Melsungen AG
Claris Lifesciences Ltd
Kyowa Hakko Bio Co., Ltd
Grifols
Liqvor Pharmaceuticals

Key Segments Covered in Intravenous Solutions Market Survey

By Type:

Total Parenteral Nutrition (TPN)
Peripheral Parenteral Nutrition (PPN)

By Nutrients:

Carbohydrates
Single Dose Amino Acid Solution
Vitamins & Minerals (Salt and Electrolyte)
Parenteral Lipid Emulsion
Other Nutrients

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1. Executive Summary

1.1. Global Intravenous Solutions Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Personal Emergency Response Systems Production Output, by Region, Value (US$ Bn) and Volume (Liters), 2018 - 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Type, US$ Per Liters, 2018 - 2023
4.2. Prominent Factor Affecting Personal Emergency Response Systems Prices
4.3. Global Average Price Analysis, by Region, US$ Per Liters

5. Global Intravenous Solutions Market Outlook, 2018 - 2031

5.1. Global Intravenous Solutions Market Outlook, by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Total Parenteral Nutrition (TPN)
  - 5.1.1.2. Peripheral Parenteral Nutrition (PPN)
5.2. Global Intravenous Solutions Market Outlook, by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Carbohydrates
  - 5.2.1.2. Single Dose Amino Acid Solution
  - 5.2.1.3. Vitamins & Minerals (Salt and Electrolyte)
  - 5.2.1.4. Parenteral Lipid Emulsion
  - 5.2.1.5. Other Nutrients
5.3. Global Intravenous Solutions Market Outlook, by Region, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. North America
  - 5.3.1.2. Europe
  - 5.3.1.3. Asia Pacific
  - 5.3.1.4. Latin America
  - 5.3.1.5. Middle East & Africa

6. North America Intravenous Solutions Market Outlook, 2018 - 2031

6.1. North America Intravenous Solutions Market Outlook, by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Total Parenteral Nutrition (TPN)
  - 6.1.1.2. Peripheral Parenteral Nutrition (PPN)
6.2. North America Intravenous Solutions Market Outlook, by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Carbohydrates
  - 6.2.1.2. Single Dose Amino Acid Solution
  - 6.2.1.3. Vitamins & Minerals (Salt and Electrolyte)
  - 6.2.1.4. Parenteral Lipid Emulsion
  - 6.2.1.5. Other Nutrients
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. North America Intravenous Solutions Market Outlook, by Country, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. U.S. Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 6.3.1.2. U.S. Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 6.3.1.3. Canada Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 6.3.1.4. Canada Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Intravenous Solutions Market Outlook, 2018 - 2031

7.1. Europe Intravenous Solutions Market Outlook, by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Total Parenteral Nutrition (TPN)
  - 7.1.1.2. Peripheral Parenteral Nutrition (PPN)
7.2. Europe Intravenous Solutions Market Outlook, by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Carbohydrates
  - 7.2.1.2. Single Dose Amino Acid Solution
  - 7.2.1.3. Vitamins & Minerals (Salt and Electrolyte)
  - 7.2.1.4. Parenteral Lipid Emulsion
  - 7.2.1.5. Other Nutrients
- 7.2.2. Attractiveness Analysis
7.3. Europe Intravenous Solutions Market Outlook, by Country, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Germany Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.2. Germany Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.3. U.K. Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.4. U.K. Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.5. France Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.6. France Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.7. Italy Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.8. Italy Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.9. Turkey Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.10. Turkey Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.11. Russia Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.12. Russia Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.13. Rest of Europe Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 7.3.1.14. Rest of Europe Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Intravenous Solutions Market Outlook, 2018 - 2031

8.1. Asia Pacific Intravenous Solutions Market Outlook, by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Total Parenteral Nutrition (TPN)
  - 8.1.1.2. Peripheral Parenteral Nutrition (PPN)
8.2. Asia Pacific Intravenous Solutions Market Outlook, by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Carbohydrates
  - 8.2.1.2. Single Dose Amino Acid Solution
  - 8.2.1.3. Vitamins & Minerals (Salt and Electrolyte)
  - 8.2.1.4. Parenteral Lipid Emulsion
  - 8.2.1.5. Other Nutrients
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Asia Pacific Intravenous Solutions Market Outlook, by Country, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. China Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.2. China Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.3. Japan Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.4. Japan Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.5. South Korea Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.6. South Korea Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.7. India Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.8. India Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.9. Southeast Asia Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.10. Southeast Asia Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.11. Rest of Asia Pacific Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 8.3.1.12. Rest of Asia Pacific Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Intravenous Solutions Market Outlook, 2018 - 2031

9.1. Latin America Intravenous Solutions Market Outlook, by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. Total Parenteral Nutrition (TPN)
  - 9.1.1.2. Peripheral Parenteral Nutrition (PPN)
9.2. Latin America Intravenous Solutions Market Outlook, by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 9.2.1. Key Highlights
  - 9.2.1.1. Carbohydrates
  - 9.2.1.2. Single Dose Amino Acid Solution
  - 9.2.1.3. Vitamins & Minerals (Salt and Electrolyte)
  - 9.2.1.4. Parenteral Lipid Emulsion
  - 9.2.1.5. Other Nutrients
- 9.2.2. BPS Analysis/Market Attractiveness Analysis
9.3. Latin America Intravenous Solutions Market Outlook, by Country, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Brazil Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.2. Brazil Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.3. Mexico Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.4. Mexico Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.5. Argentina Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.6. Argentina Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.7. Rest of Latin America Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 9.3.1.8. Rest of Latin America Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Intravenous Solutions Market Outlook, 2018 - 2031

10.1. Middle East & Africa Intravenous Solutions Market Outlook, by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 10.1.1. Key Highlights
  - 10.1.1.1. Total Parenteral Nutrition (TPN)
  - 10.1.1.2. Peripheral Parenteral Nutrition (PPN)
10.2. Middle East & Africa Intravenous Solutions Market Outlook, by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 10.2.1. Key Highlights
  - 10.2.1.1. Carbohydrates
  - 10.2.1.2. Single Dose Amino Acid Solution
  - 10.2.1.3. Vitamins & Minerals (Salt and Electrolyte)
  - 10.2.1.4. Parenteral Lipid Emulsion
  - 10.2.1.5. Other Nutrients
- 10.2.2. BPS Analysis/Market Attractiveness Analysis
10.3. Middle East & Africa Intravenous Solutions Market Outlook, by Country, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 10.3.1. Key Highlights
  - 10.3.1.1. GCC Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.2. GCC Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.3. South Africa Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.4. South Africa Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.5. Egypt Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.6. Egypt Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.7. Nigeria Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.8. Nigeria Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.9. Rest of Middle East & Africa Intravenous Solutions Market by Type, Value (US$ Bn) and Volume (Liters), 2018 - 2031
  - 10.3.1.10. Rest of Middle East & Africa Intravenous Solutions Market by Nutrients, Value (US$ Bn) and Volume (Liters), 2018 - 2031
- 10.3.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By End User vs by Type Heatmap
11.2. Company Market Share Analysis, 2022
11.3. Competitive Dashboard
11.4. Company Profiles
- 11.4.1. Fresenius Kabi
  - 11.4.1.1. Company Overview
  - 11.4.1.2. Product Portfolio
  - 11.4.1.3. Financial Overview
  - 11.4.1.4. Business Strategies and Development
- 11.4.2. Otsuka Pharmaceutical Co.
  - 11.4.2.1. Company Overview
  - 11.4.2.2. Product Portfolio
  - 11.4.2.3. Financial Overview
  - 11.4.2.4. Business Strategies and Development
- 11.4.3. Terumo Corporation
  - 11.4.3.1. Company Overview
  - 11.4.3.2. Product Portfolio
  - 11.4.3.3. Financial Overview
  - 11.4.3.4. Business Strategies and Development
- 11.4.4. Baxter International Inc
  - 11.4.4.1. Company Overview
  - 11.4.4.2. Product Portfolio
  - 11.4.4.3. Financial Overview
  - 11.4.4.4. Business Strategies and Development
- 11.4.5. B. Braun Melsungen AG
  - 11.4.5.1. Company Overview
  - 11.4.5.2. Product Portfolio
  - 11.4.5.3. Financial Overview
  - 11.4.5.4. Business Strategies and Development
- 11.4.6. ICU Medical, Inc
  - 11.4.6.1. Company Overview
  - 11.4.6.2. Product Portfolio
  - 11.4.6.3. Financial Overview
  - 11.4.6.4. Business Strategies and Development
- 11.4.7. Grifols, S.A.
  - 11.4.7.1. Company Overview
  - 11.4.7.2. Product Portfolio
  - 11.4.7.3. Financial Overview
  - 11.4.7.4. Business Strategies and Development
- 11.4.8. Amanta Healthcare
  - 11.4.8.1. Company Overview
  - 11.4.8.2. Product Portfolio
  - 11.4.8.3. Financial Overview
  - 11.4.8.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations